1/2

ABOUT

Carolina Alarco

Founder and Principal, BioStrategy Advisors LLC

 

Carolina Alarco has more than 25 years of experience in the biopharmaceutical industry in Cambridge, Massachusetts. Carolina has built a reputation for strategically building markets for rare diseases globally and successfully launching several orphan drugs. She is a dynamic, global and well-regarded senior executive in the healthcare industry.

 

Carolina has recently founded BioStrategy Advisors LLC, a strategic business consulting firm servicing small and medium-sized Biotech companies in the Massachusetts area. Specializing in biotech start-up corporate strategy, early commercial planning for assets in early-stage clinical development and commercial product launch planning for later-stage specialty therapeutics and/or orphan drugs/rare diseases. Extensive experience in developing the strategy for geographic expansion and determining go-to-market models for a solid global footprint. Assistance on finding and selecting partners for licensing, full-service distribution or 3PLs in the different regions (US, EU, Canada, Asia, LATAM). Initial alliance management. Advise on structuring terms and economics of licensing deals.

 

Most recently, Carolina was the President of Global Marketing and International Markets at Novelion Therapeutics and left upon its acquisition by Amryt in September 2019. She lead the marketing function and the ex-US, ex-EU region. Novelion acquired Aegerion Pharmaceuticals in 2017. Carolina remained in the company after the acquisition. At Aegerion, she single-handedly built the geographical footprint of the company from scratch in Latin America, Asia Pacific and Canada, through innovative go-to-market strategies. She has a keen business acumen and relentless focus on execution, consistently delivering results.

 

Prior to Novelion/Aegerion, she spent 15 years in progressive P&L leadership roles at Genzyme Corporation. In her tenure at Genzyme, Carolina played a pivotal role in several product launches globally, new market development and geographical expansion. Her contributions helped spur the company’s growth from a one-product company in the 90’s, when she joined, into a highly diversified multi-billion dollar global business. She occupied positions of top-tier importance including vice-president of the renal and endocrinology business units, senior director of international marketing and head of global marketing services for the rare diseases business (the primary profit driver of the company).

 

Before her long-tenure at Genzyme, Carolina spent almost 5 years at Abbot Laboratories, where she initiated her successful career in the industry. At Abbot, Carolina quickly progressed from product management to heading the specialty pharmaceuticals division and the nutritional products division.

 

Carolina’s passion is to bring innovative therapies for rare diseases to patients in need around the world.

Having spent most of her career working in the Rare Genetic Disorders/Orphan Drugs area, Carolina’s global capabilities include experience in the US, Europe, Latin America, Asia Pacific, Canada and the Middle East. Throughout her career, she has acquired extensive knowledge and experience in General Management, Commercial Operations, Global Marketing, Business Development, Corporate Strategy, Alliance Management and Market Development.

 

Carolina also has a strong philanthropic focus on causes such as children in need, women in science and Latino affairs.  She has recently been appointed by Governor Baker to the Massachusetts STEM Advisory Council. She currently serves as a Founding Member and Past-Chair of the Latino Council at Boston Children’s Hospital Trust and as Board Member of the CURE Rare Disease Foundation. She is co-founder and member of the Steering Committee of Latinos in Bio. She has been past-chair and Board Member of the New-England Latin America Business Council, as well as, other organizations. She holds a Bachelor of Science in Business Administration from the University of Lima (Lima, Peru) and a Graduate Degree in Business and Management from Harvard University (Cambridge, MA, USA).

©2020 Bio Strategy Advisors, LLC.. All Rights Reserved.